Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in chinese adults

Chemotherapy

Volumn 43, Issue 3, 1997, Pages 218-226

  Zhu, Zhu ^a   Wang, Ai Xia ^a   Li, Yan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Ceftriaxone; Chinese adults; Efficacy; Pharmacokinetics

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NEPHRITIS; PRIORITY JOURNAL;

EID: 0030887509     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239567     Document Type: Article

References (15)

1. Fernex M, Havas L: Introduction and review. Chemotherapy 1981;27 (suppl 1): 1-8.
2. Economics of Ceftriaxone Use. Basel, Roche, 1987.
3. Mallet E, Lerog A, Lemeland JP: Pharmacokinetics and clinical evaluation of ceftriaxone in children with purulent meningitis. 5th Mediterranean Congress of Chemotherapy, Cairo, 1986, pp 3-4.
4. Stoeckel K: Pharmacokinetics of ceftriaxone, a long-acting broad-spcctrum cephalosporin. Progress in Therapy of Bacterial Infections - A New Cephalosporin: Ceftriaxone. Bangkok, Excerpta Medica, 1983, pp 5-20.
5. Zhou HH, Chan YP, Arnold K, Sun M: Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Antimicrob Agents Chemother 1985:27:192-196.
6. Li J-T, Cheng Y-X, Zhang W-G, Chang P, Nu L-H, Zhang S-F: A comparative study on pharmacokinetics of ceftriaxone and cefotaxime in Chinese healthy volunteers. Chin J Clin Pharmacol 1989;5:129-138.
7. Li J-T, Zhang W-G, Zhang P, Cheng Y-X, Yin F: Multiple-dosc pharmacokinetics of ceftriaxone and cefotaxime in Chinese healthy adults. Chin J Clin Pharmacol 1989;5:139-146.
8. Ascalonc V, Dal Bo L: Determination of ceftriaxone, a novel cephalosporin, in plasma, urine and saliva by high-performance liquid chromatography on an NHi bonded-phase column. J Chromatogr 1983:273: 357-366.
9. Hakim L, Bourne DWA, Triggs EJ: High-performance liquid chromatographic assay of ceftriaxone, dcsace-tylcefotaxime and ceftriaxone in rat plasma. J Chromatogr 1988:424: 111-117.
10. Jungbluth GL, Jusko WJ: Ion-paired rcversed-phase high-performance liquid chromatography assay for determination of ceftriaxone in human plasma and urine. J Pharm Sc: 1989; 78:968-970.
11. Stoical C, McNamara PJ, Brandt R, Plozza-Nottebrock H, Ziegler WH: Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 1981;29:650-657.
12. Scully BE, Fu KP, Neu HC: Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection. Am J Med 1984:77: 112-116.
13. Pollock AA, Tec PE, Patel IH, Spicehandler J, Simberkoff MS, Rahal JJ Jr: Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother 1982;22:816-823.
14. Patel IH, Kaplan SA: Pharmacokinetic profile of ceftriaxone in man. Am J Med 1984;77:17-25.
15. Nakayama I, Akicda Y, Kawamura H, Kawaguchi H, Yamaji E, Ishiyama S: Fundamental studies on ceftriaxone (Ro 13-9904), a new cephalosporin antibacterial activity, absorption. excretion, metabolism and distribution to organs. Chemotherapy (Tokyo) 1984;32:98-125.